FDA expands approved use of metastatic breast cancer treatment to include male patients
The U.S. Food and Drug Administration today is extending the indication of Ibrance (palbociclib) capsules in combination with specific endocrine ...
Tag: Expands
Takeda Expands Cancer Business With $4.66 Billion Ariad Deal
Takeda Pharmaceutical Co. will expand its footprint in the U.S. oncology market with the $4.66 billion purchase of Ariad Pharmaceuticals ...
© 2023 HealthTopical - Premium WordPress news & magazine theme by HealthTopical.